Large trials confirm immunogenicity of H1N1 vaccines

The Lancet

Volumn 375, Issue 9708, 2010, Pages 6-9

  Kelly, Heath ^a   Barr, Ian ^b  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A H1N1; PANDEMIC; PRIORITY JOURNAL; SEROCONVERSION;

EID: 72949119317     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)62132-2     Document Type: Note

References (16)

1. Baker M., Kelly H., and Wilson N. Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill 14 (2009) 19370
2. Liang X.-F., Wang H.-Q., Wang J.-Z., et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet (2009) 10.1016/S0140-6736(09)62003-1 published online Dec 16.
3. US Food and Drug Administration. Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines (May, 2007). http://www.fda.gov/cber/gdlns/panfluvac.htm (accessed Dec 3, 2009).
4. European Medicines Agency. Guideline on influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context (Jan 24, 2007). http://www.emea.europa.eu/pdfs/human/vwp/26349906enfin.pdf (accessed Dec 3, 2009).
5. Vajo Z., Tamas F., Sinka L., and Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet (2009) 10.1016/S0140-6736(09)62039-0 published online Dec 16.
6. Plennevaux E., Sheldon E., Blatter M., Reeves-Hoché M.-K., and Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet (2009) 10.1016/S0140-6736(09)62026-2 published online Dec 16.
7. Greenberg M.E., Lai M.H., Hartel G.F., et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine-preliminary report. N Engl J Med (2009) 10.1056/NEJMoa0907413 published online Sept 10.
8. Clark T.W., Pareek M., Hoschler K., et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine-preliminary report. N Engl J Med (2009) 10.1056/NEJMoa0907650 published online Sept 10.
9. Al-Khayatt R., Jennings R., and Potter C. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond) 93 (1984) 301-312
10. Hobson D., Curry R.L., Beare A.S., and Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70 (1972) 767-777
11. Stephenson I., Heath A., Major D., et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 15 (2009) 1229-1252
12. Nauta J.J., Beyer W.E., and Osterhaus A.D. On the relationship between mean antibody level, seroprotection and clinical protection from influenza. Biologicals 37 (2009) 216-221
13. Hancock K., Veguilla V., Lu X., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361 (2009) 1945-1952
14. Greenbaum J.A., Kotturi M.F., Kim Y., et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA (2009) 10.1073/pnas.0911580106 published online Nov 14.
15. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361 (2009) 1925-1934
16. Kelly H.A., Grant K.A., Williams S., Fielding J., and Smith D. Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust 191 (2009) 146-169